Stephen V. Liu, MD, discusses the benefits of conducting biomarker testing for patients with advanced non–small cell lung cancer and highlights the importance of waiting for the results before selecting a targeted treatment.
Related Keywords
Stephenv Liu , , Georgetown University , Georgetown Lombardi Comprehensive Cancer Center , Thoracic Oncology , Developmental Therapeutics , Per New York Lung Cancer Symposium , News , Lung Cancer , Conference ,
comparemela.com © 2020. All Rights Reserved.